Allan Reine

2018 - Pieris Pharmaceuticals

In 2018, Allan Reine earned a total compensation of $871.3K as Chief Financial Officer at Pieris Pharmaceuticals, a 56% decrease compared to previous year.

Compensation breakdown

Bonus$131,325
Option Awards$309,145
Salary$386,250
Other$44,542
Total$871,262

Reine received $386.3K in salary, accounting for 44% of the total pay in 2018.

Reine also received $131.3K in bonus, $309.1K in option awards and $44.5K in other compensation.

Rankings

In 2018, Allan Reine's compensation ranked 9,819th out of 14,244 executives tracked by ExecPay. In other words, Reine earned more than 31.1% of executives.

ClassificationRankingPercentile
All
9,819
out of 14,244
31st
Division
Manufacturing
3,967
out of 5,762
31st
Major group
Chemicals And Allied Products
1,490
out of 2,125
30th
Industry group
Drugs
1,255
out of 1,814
31st
Industry
Pharmaceutical Preparations
965
out of 1,388
31st
Source: SEC filing on June 18, 2019.

Reine's colleagues

We found two more compensation records of executives who worked with Allan Reine at Pieris Pharmaceuticals in 2018.

2018

Stephen Yoder

Pieris Pharmaceuticals

Chief Executive Officer

2018

Louis Matis

Pieris Pharmaceuticals

Chief Development Officer

News

You may also like